Can B- cell based immunotherapy be our new perspective to exit cancer?

摘要

Stepping on to a new decade, it is a great opportunity for all of us to rethink and reconsider our conventional strategies of patient diagnosis and conventional treatment modalities. Ourextended research prospective, if widened over its present horizon, can definitely readdress our current system of therapeutic strategies. It can undoubtedly claim a better prognosis andimproved survival rates for our patients with decreased burden of morbidity.